- Alzheimer's disease is characterized in part by abnormal deposits in the brain of the peptide beta amyloid (Abeta), in the form of plaques. Recent work with a transgenic model of Abeta deposition has uncovered a remarkable capacity of antibodies to prevent or clear these deposits. These experiments offer the attractive possibility, albeit some way in the future, of using antibodies as a therapy in Alzheimer's disease.
- Publication status:
- Publisher copy:
- Copyright date:
Is an effective immune intervention for Alzheimer's disease in prospect?
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record